The groundbreaking approach of the medication represents a exciting development in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects two pathways – GLP-1 and the GIP hormone https://tirzepatidepeptide411890.amoblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-64142043